J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS)
INR 1934.75
(4.25%)
INR 1934.75
(4.25%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 7.54 Billion INR | 28.18% |
| 2022 | 5.91 Billion INR | 24.88% |
| 2021 | 4.73 Billion INR | -3.2% |
| 2020 | 4.89 Billion INR | 53.84% |
| 2019 | 3.18 Billion INR | 23.22% |
| 2018 | 2.58 Billion INR | 54.06% |
| 2017 | 1.67 Billion INR | -27.1% |
| 2016 | 2.29 Billion INR | 10.11% |
| 2015 | 2.08 Billion INR | 43.47% |
| 2014 | 1.45 Billion INR | 66.45% |
| 2013 | 874.45 Million INR | -15.57% |
| 2012 | 1.03 Billion INR | -22.16% |
| 2011 | 1.33 Billion INR | -8.73% |
| 2010 | 1.45 Billion INR | -1.54% |
| 2009 | 1.48 Billion INR | 299.53% |
| 2008 | 370.61 Million INR | -15.17% |
| 2007 | 436.89 Million INR | -38.6% |
| 2006 | 711.55 Million INR | -13.96% |
| 2005 | 827.02 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 2.39 Billion INR | 52.24% |
| 2023 Q1 | 2 Billion INR | -91.19% |
| 2023 Q4 | 1.57 Billion INR | -19.88% |
| 2023 Q2 | 2.19 Billion INR | 9.12% |
| 2023 Q3 | 1.96 Billion INR | -10.31% |
| 2023 FY | 7.58 Billion INR | 28.18% |
| 2022 Q3 | 1.49 Billion INR | -5.25% |
| 2022 Q1 | 1.46 Billion INR | 38.49% |
| 2022 FY | 5.91 Billion INR | 24.88% |
| 2022 Q4 | 22.78 Billion INR | 1424.01% |
| 2022 Q2 | 1.57 Billion INR | 7.57% |
| 2021 Q4 | 1.05 Billion INR | -4.7% |
| 2021 Q3 | 1.11 Billion INR | 0.12% |
| 2021 Q2 | 1.11 Billion INR | -23.88% |
| 2021 Q1 | 1.45 Billion INR | 38.51% |
| 2021 FY | 4.73 Billion INR | -3.2% |
| 2020 FY | 4.89 Billion INR | 53.84% |
| 2020 Q2 | 926.52 Million INR | -32.92% |
| 2020 Q3 | 1.53 Billion INR | 65.78% |
| 2020 Q4 | 1.05 Billion INR | -31.45% |
| 2020 Q1 | 1.38 Billion INR | 62.08% |
| 2019 Q1 | 801.81 Million INR | 28.95% |
| 2019 Q2 | 838.74 Million INR | 4.61% |
| 2019 Q4 | 852.21 Million INR | 16.99% |
| 2019 FY | 3.18 Billion INR | 23.22% |
| 2019 Q3 | 728.47 Million INR | -13.15% |
| 2018 Q3 | 633.17 Million INR | -5.23% |
| 2018 Q2 | 668.11 Million INR | 12.03% |
| 2018 Q1 | 596.36 Million INR | 0.0% |
| 2018 FY | 2.58 Billion INR | 54.06% |
| 2018 Q4 | 621.77 Million INR | -1.8% |
| 2017 Q1 | 260.11 Million INR | -45.21% |
| 2017 FY | 1.67 Billion INR | -27.1% |
| 2016 FY | 2.29 Billion INR | 10.11% |
| 2016 Q4 | 474.73 Million INR | 0.0% |
| 2015 FY | 2.08 Billion INR | 43.47% |
| 2015 Q4 | 632.83 Million INR | 0.0% |
| 2014 FY | 1.45 Billion INR | 66.45% |
| 2013 Q1 | 328.88 Million INR | 0.0% |
| 2013 FY | 874.45 Million INR | -15.57% |
| 2012 Q1 | 139.68 Million INR | 0.0% |
| 2012 FY | 1.03 Billion INR | -22.16% |
| 2011 FY | 1.33 Billion INR | -8.73% |
| 2010 FY | 1.45 Billion INR | -1.54% |
| 2009 FY | 1.48 Billion INR | 299.53% |
| 2008 FY | 370.61 Million INR | -15.17% |
| 2007 FY | 436.89 Million INR | -38.6% |
| 2006 FY | 711.55 Million INR | -13.96% |
| 2005 FY | 827.02 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sigachi Industries Limited | 1.47 Billion INR | -411.681% |
| Ind-Swift Limited | 1.22 Billion INR | -515.16% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Sakar Healthcare Limited | 495.5 Million INR | -1422.008% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 92.783% |
| Innova Captab Limited | 2.53 Billion INR | -197.687% |
| Divi's Laboratories Limited | 18.31 Billion INR | 58.811% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -68.57% |
| Morepen Laboratories Limited | 4.17 Billion INR | -80.689% |
| Mankind Pharma Limited | 40.86 Billion INR | 81.546% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Wanbury Limited | 1.7 Billion INR | -341.753% |
| Laurus Labs Limited | 3.94 Billion INR | -90.995% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -93.843% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 16.01% |
| Alembic Limited | 767.77 Million INR | -882.279% |
| Hikal Limited | 1.49 Billion INR | -404.728% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -30.974% |
| Neuland Laboratories Limited | 5.31 Billion INR | -41.811% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -15.983% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -52.597% |
| Themis Medicare Limited | 1.3 Billion INR | -478.744% |
| RPG Life Sciences Limited | 2.29 Billion INR | -228.999% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 83.386% |
| Lupin Limited | 27.75 Billion INR | 72.831% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -1114.382% |
| Wockhardt Limited | 140 Million INR | -5286.886% |
| Vaishali Pharma Limited | 6.29 Million INR | -119722.704% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -141.092% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -3423.473% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -45.339% |
| FDC Limited | 3.03 Billion INR | -148.592% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 88.865% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -3524.918% |
| Eris Lifesciences Limited | 5.18 Billion INR | -45.543% |
| Venus Remedies Limited | 534.65 Million INR | -1310.573% |
| ZIM Laboratories Limited | 1.09 Billion INR | -586.782% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -512.643% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -1267.257% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | -4.378% |
| Shilpa Medicare Limited | 3.76 Billion INR | -100.492% |
| Albert David Limited | 1.33 Billion INR | -465.147% |
| Ajanta Pharma Limited | 19.67 Billion INR | 61.673% |
| Hester Biosciences Limited | 364.77 Million INR | -1967.506% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -63.677% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 295.739% |
| Gufic Biosciences Limited | 2.89 Billion INR | -160.613% |
| Windlas Biotech Limited | 1.29 Billion INR | -480.622% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -170.698% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -266311.323% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -27366.097% |
| Granules India Limited | 6.52 Billion INR | -15.523% |
| Aarti Drugs Limited | 7.14 Billion INR | -5.496% |
| Bal Pharma Limited | 214.56 Million INR | -3414.786% |
| Alkem Laboratories Limited | 19.46 Billion INR | 61.249% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 92.77% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -295.611% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -3073.277% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -36410.655% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Orchid Pharma Limited | 2.36 Billion INR | -219.415% |
| Medico Remedies Limited | 277.11 Million INR | -2621.455% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -275.387% |
| Ipca Laboratories Limited | 29.59 Billion INR | 74.518% |
| Brooks Laboratories Limited | -72.25 Million INR | 10537.968% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -2925.721% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 70.233% |
| NATCO Pharma Limited | 25.96 Billion INR | 70.951% |
| Suven Life Sciences Limited | -1.22 Billion INR | 715.231% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -44.315% |
| Indoco Remedies Limited | 1.52 Billion INR | -394.728% |
| Alpa Laboratories Limited | 61.51 Million INR | -12159.841% |
| Lasa Supergenerics Limited | -458 Million INR | 1746.629% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 283.27% |